| 发明名称 | Use of GSTP1 | ||
| 摘要 | The invention discloses the use of glutathione S-transferase P1 (GSTP1) for the prevention or treatment of cardiomyopathies or ischemic heart diseases and for the diagnosis thereof. | ||
| 申请公布号 | US8758745(B2) | 申请公布日期 | 2014.06.24 |
| 申请号 | US201013505078 | 申请日期 | 2010.10.28 |
| 申请人 | Medizinische Universitaet Wien | 发明人 | Aharinejad Seyedhossein |
| 分类号 | A61K38/45;A61P9/10 | 主分类号 | A61K38/45 |
| 代理机构 | Agris & von Natzmer LLP | 代理人 | Natzmer Joyce von;Agris & von Natzmer LLP |
| 主权项 | 1. A method for treating cardiomyopathy (CMP) or ischemic heart disease (IHD) comprising: administering to a human individual in need thereof glutathione S-transferase P1 (GSTP1) in an amount effective to treat CMP or, IHD, wherein the human individual in need thereof is a patient having been diagnosed with CMP and/or IHD. | ||
| 地址 | Vienna AT | ||